111 related articles for article (PubMed ID: 7594031)
21. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method.
van Rugge FP; van der Wall EE; Spanjersberg SJ; de Roos A; Matheijssen NA; Zwinderman AH; van Dijkman PR; Reiber JH; Bruschke AV
Circulation; 1994 Jul; 90(1):127-38. PubMed ID: 8025988
[TBL] [Abstract][Full Text] [Related]
22. Dobutamine stress induced severe prolonged left ventricular dysfunction.
Müller H
Arch Cardiovasc Dis; 2008 Jun; 101(6):429-30. PubMed ID: 18809158
[No Abstract] [Full Text] [Related]
23. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease.
van Rugge FP; van der Wall EE; de Roos A; Bruschke AV
J Am Coll Cardiol; 1993 Aug; 22(2):431-9. PubMed ID: 8335812
[TBL] [Abstract][Full Text] [Related]
24. Dobutamine stress-induced ischemic right ventricular dysfunction and its relation to cardiac output in patients with three-vessel coronary artery disease with angina-like symptoms.
O'Sullivan CA; Duncan A; Daly C; Li W; Oldershaw P; Henein MY
Am J Cardiol; 2005 Sep; 96(5):622-7. PubMed ID: 16125482
[TBL] [Abstract][Full Text] [Related]
25. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease.
Barnes E; Hall RJ; Dutka DP; Camici PG
J Am Coll Cardiol; 2002 Feb; 39(3):420-7. PubMed ID: 11823079
[TBL] [Abstract][Full Text] [Related]
26. Objective evaluation of regional left ventricular wall motion during dobutamine stress echocardiographic studies using segmental analysis of color kinesis images.
Koch R; Lang RM; Garcia MJ; Weinert L; Bednarz J; Korcarz C; Coughlan B; Spiegel A; Kaji E; Spencer KT; Mor-Avi V
J Am Coll Cardiol; 1999 Aug; 34(2):409-19. PubMed ID: 10440153
[TBL] [Abstract][Full Text] [Related]
27. Relation between exercise and dobutamine stress-induced wall motion abnormalities and severity and location of stenosis in single-vessel coronary artery disease.
Tousoulis D; Rallidis L; Cokkinos P; Davies G; Nihoyannopoulos P
Am Heart J; 1999 Nov; 138(5 Pt 1):873-9. PubMed ID: 10539818
[TBL] [Abstract][Full Text] [Related]
28. Comparison of coronary endothelial dynamics with electrocardiographic and left ventricular contractile responses to stress in the absence of coronary artery disease.
Cannon RO; Curiel RV; Prasad A; Quyyumi AA; Panza JA
Am J Cardiol; 1998 Sep; 82(6):710-4. PubMed ID: 9761078
[TBL] [Abstract][Full Text] [Related]
29. Relation between ischemic threshold measured during dobutamine stress echocardiography and known indices of poor prognosis in patients with coronary artery disease.
Panza JA; Curiel RV; Laurienzo JM; Quyyumi AA; Dilsizian V
Circulation; 1995 Oct; 92(8):2095-101. PubMed ID: 7554187
[TBL] [Abstract][Full Text] [Related]
30. Regional wall motion changes with dobutamine as a pharmacological stress test during cardiac catheterization in patients with significant coronary artery disease.
Wagdi P; Fluri M; Rouvinez G; Meier B
Jpn Heart J; 1996 Nov; 37(6):847-53. PubMed ID: 9057679
[TBL] [Abstract][Full Text] [Related]
31. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease.
Krivokapich J; Czernin J; Schelbert HR
J Am Coll Cardiol; 1996 Sep; 28(3):565-72. PubMed ID: 8772740
[TBL] [Abstract][Full Text] [Related]
32. Interobserver and intraobserver variation for analysis of left ventricular wall motion at baseline and during low- and high-dose dobutamine stress echocardiography in patients with high prevalence of wall motion abnormalities at rest.
Bjørnstad K; al Amri M; Lingamanaicker J; Oqaili I; Hatle L
J Am Soc Echocardiogr; 1996; 9(3):320-8. PubMed ID: 8736017
[TBL] [Abstract][Full Text] [Related]
33. Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery disease.
Pennell DJ; Firmin DN; Burger P; Yang GZ; Manzara CC; Ell PJ; Swanton RH; Walker JM; Underwood SR; Longmore DB
Br Heart J; 1995 Aug; 74(2):163-70. PubMed ID: 7546996
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging during dobutamine stress in coronary artery disease.
Pennell DJ; Underwood SR; Manzara CC; Swanton RH; Walker JM; Ell PJ; Longmore DB
Am J Cardiol; 1992 Jul; 70(1):34-40. PubMed ID: 1615867
[TBL] [Abstract][Full Text] [Related]
35. Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardium.
Sawada SG; Safadi A; Gaitonde RS; Tung N; Mahenthiran J; Gill W; Ghumman W; Gradus-Pizlo I; Kamalesh M; Fineberg N; Feigenbaum H
Echocardiography; 2007 Aug; 24(7):739-44. PubMed ID: 17651103
[TBL] [Abstract][Full Text] [Related]
36. Effect of dobutamine on regional left ventricular function measured by tagged magnetic resonance imaging in normal subjects.
Scott CH; Sutton MS; Gusani N; Fayad Z; Kraitchman D; Keane MG; Axel L; Ferrari VA
Am J Cardiol; 1999 Feb; 83(3):412-7. PubMed ID: 10072234
[TBL] [Abstract][Full Text] [Related]
37. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.
Schneider CA; Voth E; Moka D; Baer FM; Melin J; Bol A; Wagner R; Schicha H; Erdmann E; Sechtem U
J Am Coll Cardiol; 1999 Oct; 34(4):1005-11. PubMed ID: 10520782
[TBL] [Abstract][Full Text] [Related]
38. [Dobutamine stress cardiovascular magnetic resonance imaging in patients with peripheral artery disease].
Kirschner R; Pécsvárady Z; Bedros JR; Tóth L; Kiss K; Simor T
Orv Hetil; 2011 Feb; 152(8):285-91. PubMed ID: 21310697
[TBL] [Abstract][Full Text] [Related]
39. Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease.
Chierchia SL
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S19-21. PubMed ID: 11286302
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of dobutamine stress testing in women with suspected coronary artery disease.
Blomstrand P; Engvall J; Swahn E; Säfström K; Thulesius O; Wranne B
Heart; 1996 May; 75(5):463-8. PubMed ID: 8665338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
